Angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibitor–induced angioedema: A disproportionality analysis of the WHO pharmacovigilance database
Marion Lepelley(Centre Hospitalier Universitaire de Grenoble), Laurence Bouillet(University of California, Irvine), Charles Khouri(Centre Hospitalier Universitaire de Grenoble), Clémence Lacroix(Aix-Marseille Université)
Cited by 16
Related Papers
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
|The Journal of Allergy and Clinical Immunology In Practice|2019|80
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
|Journal of the American Academy of Dermatology|2022|67
Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
|Journal of the Neurological Sciences|2019|60
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48